The electrophysiology devices market was valued at USD 9.37 Billion in 2025. It is poised to grow at a CAGR of 12.40% during the forecast period of 2026-2035, and reach USD 30.16 Billion by 2035. The growth is driven by the rising prevalence of atrial fibrillation, rapid adoption of pulsed field ablation systems, and broader use of advanced 3D mapping platforms across hospitals and ambulatory surgical centres worldwide.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic, headquartered in Galway, Ireland, supplies the PulseSelect and Affera Pulsed Field Ablation systems. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, becoming the first company with two FDA-approved PFA platforms for atrial fibrillation.
Boston Scientific Corporation is a leading provider of electrophysiology devices, offering advanced technologies such as mapping catheters and radiofrequency ablation systems for diagnosing and treating cardiac arrhythmias. Its S-ICD™ System enables defibrillation without contacting the heart, enhancing patient safety. The company plays a significant role in advancing minimally invasive cardiac rhythm management solutions worldwide.
Abbott is a key player in the market, supplies cardiac mapping, ablation, and rhythm management products, including the EnSite X EP system. In March 2025, Abbott received CE mark approval for the Volt Pulsed Field Ablation System for atrial fibrillation, expanding its electrophysiology footprint across markets.
Other key players in the market are Biosense Webster, Inc., GE HealthCare Technologies Inc., MicroPort Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., and CathVision ApS.
Latest News on the Electrophysiology Devices Market (2026)
April 2026: Stereotaxis Wins FDA 510(k) Clearance for Synchrony Robotic EP Cockpit
Stereotaxis announced FDA 510(k) clearance on April 6, 2026 for the Synchrony System, a digital cockpit designed for robotic electrophysiology labs that integrates 4K visualization, multi-system control, and SynX cloud connectivity. According to DAIC, the platform is positioned to streamline complex ablation procedures and accelerate the broader shift toward digital, robotically navigated cardiac care across the electrophysiology devices market.March 2026: Boston Scientific Wins Expanded CE Mark for Farapulse Persistent AF
Boston Scientific received expanded CE mark approval on March 3, 2026 for its Farapulse Pulsed Field Ablation System to treat persistent atrial fibrillation, building on positive ADVANTAGE AF clinical trial data. As reported by Cardiovascular Business, the broader European label strengthens Boston Scientific's leadership in pulsed field ablation and reshapes competitive dynamics across the global electrophysiology devices market.Key Market Trends and Insights
- By indication, the atrial fibrillation segment held approximately 73% market share in the historical period.
- Based on the end user, the hospitals segment is expected to hold the largest market share in the forecast period.
- North America accounted for around 49% market share in the historical period.
Market Size and Forecast
- Market Size (2025) : USD 9.37 Billion
- Projected Market Size (2035) : USD 30.16 Billion
- CAGR (2026-2035) : 12.40%
- Largest Market in 2025 : North America
Electrophysiology Devices Market Overview
Electrophysiology devices are specialised diagnostic and therapeutic medical devices used to map, monitor, and treat cardiac arrhythmias such as atrial fibrillation, supraventricular tachycardia, and bradycardia. They include ablation catheters, mapping systems, ECG monitors, pacemakers, implantable cardioverter defibrillators, and insertable cardiac monitors. The market was valued at USD 9.37 Billion in 2025 and is poised to grow at a CAGR of 12.40%. The market is experiencing steady growth driven by the rising prevalence of cardiovascular disorders, increasing adoption of minimally invasive procedures, and continuous technological advancements. Integration of AI diagnostics, clinical decision support, and biomarker-based treatment approaches is enhancing procedural efficiency and patient stratification.Electrophysiology Devices Market Growth Drivers
Rising Global Burden of Atrial Fibrillation is Set to Boost the Market Value
The growing burden of cardiac arrhythmia is the leading driver of demand for electrophysiology devices. As per Siyuan Cheng et al., 2024, atrial fibrillation and flutter affected approximately 52.55 million people worldwide in 2021, with 4.48 million new cases that year. This growing patient pool is accelerating the demand for advanced electrophysiology procedures, including catheter ablation and diagnostic mapping. The rising clinical need for early diagnosis and effective rhythm management continues to strengthen the adoption of electrophysiology devices, thereby contributing to sustained market growth.Electrophysiology Devices Market Trends
A notable trend in the market is the rapid clinical adoption of pulsed field ablation as a safer, more efficient alternative to thermal ablation for atrial fibrillation:
Increasing Adoption of Pulsed Field Ablation Platforms is Likely to Enhance the Market Growth
The market is witnessing a strong shift toward next-generation ablation technologies, particularly pulsed field ablation (PFA), which offers improved safety and procedural efficiency compared to conventional thermal methods. In January 2024, Boston Scientific received U.S. FDA approval for its FARAPULSE™ pulsed field ablation system for treating atrial fibrillation, demonstrating strong clinical outcomes and real-world safety data. This advancement is expected to accelerate adoption and significantly drive market growth.Electrophysiology Devices Market Segmentation
Market Breakup by Product
- Equipment
- EP Laboratory Capital Equipment 3-D Mapping Systems Recording Systems RF Generators and Cryo Consoles Others
- Implantable Electrophysiology Devices Cardiac Pacemakers Implantable Cardioverter-Defibrillators (ICDs)
- Catheters
- Diagnostic EP Catheters
- Ablation Catheters
- Others
Market Breakup by Application
- Atrial Fibrillation
- Atrial Flutter
- Atrioventricular Nodal Re-entrant Tachycardia (AVNRT)
- Wolff-Parkinson-White (WPW) Syndrome
- Ventricular Tachycardia
- Other Arrhythmias
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Electrophysiology Laboratories
- Academic and Research Institute
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Electrophysiology Devices Market Share
Catheters Segment is Poised to Witness Significant Growth Based on the Product
The market is segmented by product into equipment and catheters, each playing a critical role in electrophysiology procedures. Equipment includes mapping systems, recording systems, and ablation generators, while catheters comprise diagnostic and ablation variants essential for intracardiac interventions. Among these, catheters are expected to lead the segment due to their indispensable use in minimally invasive cardiac procedures and increasing adoption in arrhythmia management. The rising procedural volumes and continuous innovation in catheter design are key growth drivers. Recent advancements and product approvals in 2024 and 2025 further reinforce their dominance, supporting sustained segment growth.Electrophysiology Devices Market Analysis by Region
Among all the regions, North America is expected to lead the market, supported by advanced surgical infrastructure, high atrial fibrillation prevalence, and a dense network of specialised electrophysiology laboratories. For instance, in April 2025, Merit Medical Systems, Inc. announced the United States commercial launch of its Ventrax delivery system, designed to improve catheter access in ventricular tachycardia ablation procedures. This development supports market growth by enhancing procedural efficiency and clinical outcomes in electrophysiology interventions.Leading Players in the Electrophysiology Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Medtronic, headquartered in Galway, Ireland, supplies the PulseSelect and Affera Pulsed Field Ablation systems. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, becoming the first company with two FDA-approved PFA platforms for atrial fibrillation.Medtronic, headquartered in Galway, Ireland, supplies the PulseSelect and Affera Pulsed Field Ablation systems. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, becoming the first company with two FDA-approved PFA platforms for atrial fibrillation.
Boston Scientific Corporation
Boston Scientific Corporation is a leading provider of electrophysiology devices, offering advanced technologies such as mapping catheters and radiofrequency ablation systems for diagnosing and treating cardiac arrhythmias. Its S-ICD™ System enables defibrillation without contacting the heart, enhancing patient safety. The company plays a significant role in advancing minimally invasive cardiac rhythm management solutions worldwide.Boston Scientific Corporation is a leading provider of electrophysiology devices, offering advanced technologies such as mapping catheters and radiofrequency ablation systems for diagnosing and treating cardiac arrhythmias. Its S-ICD™ System enables defibrillation without contacting the heart, enhancing patient safety. The company plays a significant role in advancing minimally invasive cardiac rhythm management solutions worldwide.
Abbott Laboratories
Abbott is a key player in the market, supplies cardiac mapping, ablation, and rhythm management products, including the EnSite X EP system. In March 2025, Abbott received CE mark approval for the Volt Pulsed Field Ablation System for atrial fibrillation, expanding its electrophysiology footprint across markets.Abbott is a key player in the market, supplies cardiac mapping, ablation, and rhythm management products, including the EnSite X EP system. In March 2025, Abbott received CE mark approval for the Volt Pulsed Field Ablation System for atrial fibrillation, expanding its electrophysiology footprint across markets.
Biotronik SE & Co KG
Biotronik, headquartered in Berlin, Germany, develops cardiac rhythm management devices including pacemakers, implantable cardioverter defibrillators, and CRT-D systems. The company supplies arrhythmia management solutions across more than 100 countries and continues to expand its electrophysiology and remote patient monitoring portfolio.Other key players in the market are Biosense Webster, Inc., GE HealthCare Technologies Inc., MicroPort Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., and CathVision ApS.
Key Questions Answered in the Electrophysiology Devices Market Report
- What was the electrophysiology devices market value in 2025?
- What is the electrophysiology devices market forecast outlook for 2026-2035?
- What major factors aid the demand for the electrophysiology devices market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major electrophysiology devices market trends?
- Which product is expected to dominate the market segment?
- Which application is projected to lead the market segment?
- Which end user is anticipated to drive the market segment?
- Which region is anticipated to lead the global electrophysiology devices market?
- Who are the key players in the electrophysiology devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
1 Preface
3 Global Electrophysiology Devices Market Overview
4 Global Electrophysiology Devices Market Landscape
5 Global Electrophysiology Devices Market Dynamics
6 Global Electrophysiology Devices Market Segmentation (219-2035)
7 North America Electrophysiology Devices Market (219-2035)
8 Europe Electrophysiology Devices Market (219-2035)
9 Asia Pacific Electrophysiology Devices Market (219-2035)
10 Latin America Electrophysiology Devices Market (219-2035)
11 Middle East and Africa Electrophysiology Devices Market (219-2035)
12 Regulatory Framework
13 Patent Analysis
14 Funding and Investment Analysis
15 Strategic Initiatives
16 Supplier Landscape
17 Global Electrophysiology Devices Market - Distribution Model (Additional Insight)
Companies Mentioned
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Biotronik SE & Co KG
